These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 10861807
1. Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia. Nakasaki T, Wada H, Mori Y, Okugawa Y, Watanabe R, Nishikawa M, Gabazza EC, Masuya M, Kageyama S, Kumeda K, Kato H, Shiku H. Am J Hematol; 2000 Jul; 64(3):145-50. PubMed ID: 10861807 [Abstract] [Full Text] [Related]
2. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia. Zhao W, Wang H, Wang X, Wu F, Guo W, Qu B, Shen Z, Wang Z. Thromb Res; 2001 May 01; 102(3):197-204. PubMed ID: 11369412 [Abstract] [Full Text] [Related]
3. Hemostatic molecular markers before the onset of disseminated intravascular coagulation. Wada H, Sakuragawa N, Mori Y, Takagi M, Nakasaki T, Shimura M, Hiyoyama K, Nisikawa M, Gabazza EC, Deguchi K, Kazama M, Shiku H. Am J Hematol; 1999 Apr 01; 60(4):273-8. PubMed ID: 10203100 [Abstract] [Full Text] [Related]
5. [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia]. Wu F, Wang X, Zhao W, Wang H, Shen Z. Zhonghua Nei Ke Za Zhi; 2001 Jan 01; 40(1):36-9. PubMed ID: 11798557 [Abstract] [Full Text] [Related]
8. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia. Tallman MS, Lefèbvre P, Baine RM, Shoji M, Cohen I, Green D, Kwaan HC, Paietta E, Rickles FR. J Thromb Haemost; 2004 Aug 01; 2(8):1341-50. PubMed ID: 15304040 [Abstract] [Full Text] [Related]
9. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group. Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Deguchi K, Shiku H. Pol J Pharmacol; 1996 Aug 01; 48(2):225-8. PubMed ID: 9112656 [Abstract] [Full Text] [Related]
12. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T. Am J Hematol; 2003 Jan 01; 72(1):1-7. PubMed ID: 12508260 [Abstract] [Full Text] [Related]
15. Characteristics of fibrinolytic disorders in acute promyelocytic leukemia. Wang P, Zhang Y, Yang H, Hou W, Jin B, Hou J, Li H, Zhao H, Zhou J. Hematology; 2018 Dec 01; 23(10):756-764. PubMed ID: 29724147 [Abstract] [Full Text] [Related]